DIA Biosimilars 2013

Awards & Advancement

Mytrus appoints Anthony Costello as CEO

Friday, July 6, 2012 01:33 PM

Mytrus, a San Francisco-based clinical technology and services company for medical and pharmaceutical research, has appointed Anthony J. Costello as CEO. He

More... »

Cenduit: Now with Patient Reminders

Icon appoints three to senior clinical and laboratory positions

Tuesday, July 3, 2012 10:49 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has appointed three additions to the senior management teams of its clinical and central laboratories businesses.

More... »

CRF Health – eCOA Forum

OTTLIV names winners of first Innovation Trophies

Monday, July 2, 2012 12:04 PM

OTTLIV, the technology transfer arm of Assistance Publique-Hopitaux de Paris (AP-HP), a network of 37 Paris hospitals and universities, has announced the results of the first Innovation Trophies, designed to mark outstanding promise resulting from research within AP-HP.

More... »

Sequenom appoints Carolyn Beaver as chief accounting officer

Friday, June 29, 2012 11:14 AM

Sequenom, a San Diego-based life sciences company providing innovative genetic analysis solutions, has appointed Carolyn Beaver as vice president and chief accounting officer.

More... »

Anavex appoints Robert Chisholm as CFO

Friday, June 29, 2012 11:01 AM

Anavex Life Sciences, a pharmaceutical company based in Vancouver, has appointed Robert Chisholm as chief financial officer.

More... »

Pfizer’s Karen Bien elected to board of SAFE-BioPharma

Friday, June 29, 2012 09:57 AM

Karen Bien, director of business technology on Pfizer’s acquisition, collaboration and divestiture team, has been elected to the board of directors of SAFE-BioPharma Association, the strategic non-profit collaboration that developed and manages the global SAFE-BioPharma digital identity and digital signature standard for the life science and healthcare sectors.

More... »

AcademyHealth recognizes McGlynn with Distinguished Investigator Award

Thursday, June 28, 2012 12:18 PM

AcademyHealth, a national organization serving the fields of health services, policy research and professionals, has named Elizabeth McGlynn, Ph.D., as the 2012 recipient of its Distinguished Investigator Award.

More... »

Exco InTouch named ‘Microsoft Managed Partner’ within life sciences

Wednesday, June 27, 2012 02:51 PM

Exco InTouch, a provider of mobile patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, has been named a Microsoft Managed Partner.

More... »

Paragonix Technologies names Leonard A. R. Golding as CMO

Monday, June 25, 2012 11:11 AM

Paragonix Technologies, a medical device company of Cambridge, Mass., has appointed Leonard A. R. Golding, MB, BS, FRACS, FRCS(C), FACC, as chief medical officer.

More... »

CRA honored with 5 STEVIE Awards

Friday, June 22, 2012 02:05 PM

Tempe, Ariz.-based Clinical Research Advantage, a community-based network of clinical trial sites, was honored with three silver and two bronze STEVIE Awards at the 10th Annual American Business Awards on June 18. 

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs